Skip to search boxSkip to navigationSkip to main content

Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families

  • on behalf of the GenoMEL Study Group
    ,
  • John Charles A. Lacson(Author)
    ,
  • Shawn A. Zamani(Author)
    ,
  • Luis Alberto Ribeiro Froes(Author)
    ,
  • Nandita Mitra(Author)
    ,
  • Lu Qian(Author)
*Corresponding author for this work
  • University of South Florida
    ,
  • University of Cambridge
    ,
  • Universidade de São Paulo
    ,
  • University of Pennsylvania
    ,
  • Fred Hutchinson Cancer Research Center
    ,
  • Sheba Medical Center at Tel Hashomer
Research Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
FWCI
0.39
SciVal
Author count
38
SciVal
Paper percentile
46
SciVal
Citations
4
Scopus
Citations

Abstract

Background: Individuals from melanoma-prone families have similar or reduced sun-protective behaviors compared to the general population. Studies on trends in sun-related behaviors have been temporally and geographically limited. Methods: Individuals from an international consortium of melanoma-prone families (GenoMEL) were retrospectively asked about sunscreen use, sun exposure (time spent outside), sunburns, and sunbed use at several timepoints over their lifetime. Generalized linear mixed models were used to examine the association between these outcomes and birth cohort defined by decade spans, after adjusting for covariates. Results: A total of 2407 participants from 547 families across 17 centers were analyzed. Sunscreen use increased across subsequent birth cohorts, and although the likelihood of sunburns increased until the 1950s birth cohort, it decreased thereafter. Average sun exposure did not change across the birth cohorts, and the likelihood of sunbed use increased in more recent birth cohorts. We generally did not find any differences in sun-related behavior when comparing melanoma cases to non-cases. Melanoma cases had increased sunscreen use, decreased sun exposure, and decreased odds of sunburn and sunbed use after melanoma diagnosis compared to before diagnosis. Conclusions: Although sunscreen use has increased and the likelihood of sunburns has decreased in more recent birth cohorts, individuals in melanoma-prone families have not reduced their overall sun exposure and had an increased likelihood of sunbed use in more recent birth cohorts. These observations demonstrate partial improvements in melanoma prevention and suggest that additional intervention strategies may be needed to achieve optimal sun-protective behavior in melanoma-prone families.

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

692

Pages from-to (Number of pages)

Pages 692

Journal (Volume, Issue Number)

BMC Public Health (Volume 21, Issue 1)

Publication milestones

  • Published - 12/2021

Publication status

Published - 12/2021

ISSN

1471-2458

Publication IDs

  • Scopus: 85104702573
  • PubMed: 33888076

Funding Details

We acknowledge the contributions of the participants, their families and the many clinicians, geneticists, genetic counsellors and allied health professionals involved in their management. This work was performed in participation with members of the following study centers: Barcelona, ES: Paula Aguilera, Ll\u00FAcia Al\u00F3s, Celia Badenas, Alicia Barreiro, Neus Calbet, Cristina Carrera, Carlos Conill, Mireia Dom\u00EDnguez, Daniel Gabriel, Pablo Iglesias, Josep Malvehy, M. Eugenia Moliner, Javiera P\u00E9rez, Ramon Pigem, Miriam Potrony, Joan Anton Puig Butille, Ramon Rull, Marcelo S\u00E1nchez, Gemma Tell-Mart\u00ED, Sergi Vidal-Sicart, and Oriol Yelamos. Genoa, IT: Giovanna Bianchi-Scarr\u00E0, Lorenza Pastorino, Virginia Andreotti, Claudia Martinuzzi, Bruna Dalmasso, Giulia Ciccarese, Francesco Spagnolo, and Paola Queirolo. Leeds, UK: Linda Whitaker, Paul Affleck, Jennifer H. Barrett, Jane Harrison, Mark M. Iles, Juliette Randerson-Moor, John C. Taylor, Kairen Kukalizch, Susan Leake, Birute Karpavicius, Sue Haynes, Tricia Mack, May Chan, and Yvonne Taylor. Leiden, NL: Clasine van der Drift, Leny van Mourik, Wilma Bergman, Femke de Snoo, Jeanet ter Huurne, and Frans van Nieuwpoort. Lund. SE: wishes to thank Anita Zander, R.N. for invaluable help with the data from the Lund Melanoma Study Group and acknowledge Kari Nielsen, Anna M\u00E5sb\u00E4ck, Katja Harbst, Goran Jonsson and \u00C5ke Borg. Mexico, MX : the authors thank Victoria Godinez Puig from Mexico for helping to collect patient samples and data. Montevideo, UY: Virginia Barquet, Javiera P\u00E9rez, Miguel Mart\u00EDnez, Jimena N\u00FA\u00F1ez, and Malena Scarone. Philadelphia, PA, US (University of Pennsylvania): acknowledges the contributions of Patricia Van Belle, Althea Ruffin, Jillian Knorr, and Wenting Zhou. Porto Alegre, BR: Renan Rangel Bonamigo and Maria Carolina Widholzer Rey. Riga, LV: Kristine Azarjana, Simona Donina, Olita Heisele, Baiba \u0160treinerte, Aija Ozola and Ludmila Engele. S\u00E3o Paulo, BR: Dirce Maria Carraro, Alexandre Leon Ribeiro de \u00C1vila, Bianca Costa Soares de S\u00E1, Maria Isabel Waddington Achatz, and Jo\u00E3o Duprat. Throughout data collection, Gilles Landman was affiliated with the AC Camargo Cancer Center, S\u00E3o Paulo, Brazil. Stockholm, SE: wishes to thank Diana Lind\u00E9n, R.N. for excellent work collecting and entering data into the study data base and Rainer Tuominen for screening of CDKN2A. Sydney, AU: Caroline Watts, Gayathri St. George, Robyn Dalziell and Kate McBride who assisted with recruitment of study participants; Leo Raudonikis who assisted with data management; and Chantelle Agha-Hamilton and Svetlana Pianova who assisted with biospecimen management. Tel Aviv, IL: wishes to acknowledge Esther Azizi, Yael Laitman. This work was supported by: the European Commission under the 6th and 7th Framework Programme [LSH-CT-2006-018702] to JNB; Cancer Research UK Programme Awards (C588/A4994 and C588/ A10589) to DTB/JNB; a Cancer Research UK Project Grant (C8216/A6129) to DTB/JNB; the US National Institutes of Health [R01 CA83115 (PAK, DEE, DTB)], the National Health and Medical Research Council of Australia [NHMRC 107359, 402761, 633004, 566946, 211172, 1093017, 1147843 (AC)]; the Cancer Council New South Wales (project grant 77/00, 06/10); the Cancer Institute New South Wales [CINSW 05/TPG/1-01, 10/TPG/1-02], 15/CDF/1-14 (AC); CAPES (Coordena\u00E7\u00E3o de Aperfei\u00E7oamento de Pessoal de N\u00EDvel Superior); FAPESP (Funda\u00E7\u00E3o para o Amparo da Pesquisa do Estado de S\u00E3o Paulo) \u2013 SP, Brazil # 2007/04313-2; the Cancer Research Foundations of Radiumhemmet and the Swedish Cancer Society; the Paulsson Trust, Lund University; grant support from the Swedish Cancer Society and European Research Council Advanced Grant (ERC-2011-294576); the research at the Melanoma Unit in Barcelona is partially funded by Spanish Fondo de Investigaciones Sanitarias grants PI15/00716 and PI15/00956; CIBER de Enfermedades Raras of the Instituto de Salud Carlos III, Spain, co-financed by European Regional Development Fund \u201CA way to achieve Europe\u201D ERDF; AGAUR 2014_SGR_603 of the Catalan Government, Spain; Diagnoptics; a grant from \u201CFundaci\u00F3 La Marat\u00F3 de TV3\u201D 201331-30, Catalonia, Spain; a grant from \u201CFundaci\u00F3n Cient\u00EDfica de la Asociaci\u00F3n Espa\u00F1ola Contra el C\u00E1ncer\u201D GCB15152978SOEN, Spain, and CERCA Programme / Generalitat de Catalunya. Part of the work was carried out at the Esther Koplowitz Center, Barcelona; Italian Ministry of Health RF-2016-02362288 to PG; the Comisi\u00F3n Honoraria de Lucha Contra el C\u00E1ncer, CSIC, Fundaci\u00F3n Manuel P\u00E9rez, Montevideo, Uruguay; Francisco Cuellar is supported by a scholarship awarded by CONACYT, Mexico (152256/158706).
FundersFunding numbers
Åke Borg
-
Fundación Manuel Pérez
-
ISCIII
-
Radiumhemmets Forskningsfonder
-
Generalitat de Catalunya
-
Cancerfonden
-
CAPES
-
AECC
-
EC
-
Lunds Universitet
-
Fundació la Marató de TV3
-
Cancer Institute NSW
-
Paulsson Trust
-
Frans van Nieuwpoort
-
ERDF
-
CINSW
10/TPG/1-02, 15/CDF/1-14, 05/TPG/1-01
CONACYT
152256/158706
FP7
294576, LSH-CT-2006-018702
AGAUR
2014_SGR_603
NHMRC
1147843, 211172, 633004, 107359, 566946, 1093017, 402761
FAPESP
2007/04313-2
Cancer Council NSW
06/10, 77/00
ERC
ERC-2011-294576
NIH
R01 CA83115
Spanish Fondo de Investigaciones Sanitarias
PI15/00956, PI15/00716
Ministero della Salute
RF-2016-02362288
CRUK
C8216/A6129, C588/A4994, C588/ A10589